Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics

INTRODUCTION: Aripiprazole and olanzapine are atypical antipsychotics. Both drugs can induce metabolic changes; however, the metabolic side effects produced by aripiprazole are more benign. The aim of the study was to evaluate if aripiprazole and olanzapine alter prolactin levels, lipid and glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Koller, Dora, Almenara, Susana, Mejía, Gina, Saiz-Rodríguez, Miriam, Zubiaur, Pablo, Román, Manuel, Ochoa, Dolores, Navares-Gómez, Marcos, Santos-Molina, Elena, Pintos-Sánchez, Elena, Abad-Santos, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889573/
https://www.ncbi.nlm.nih.gov/pubmed/33278020
http://dx.doi.org/10.1007/s12325-020-01566-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889573/
https://www.ncbi.nlm.nih.gov/pubmed/33278020
http://dx.doi.org/10.1007/s12325-020-01566-w

Ejemplares similares